Unknown

Dataset Information

0

Noninvasive, Targeted, and Non-Viral Ultrasound-Mediated GDNF-Plasmid Delivery for Treatment of Parkinson's Disease.


ABSTRACT: Glial cell line-derived neurotrophic factor (GDNF) supports the growth and survival of dopaminergic neurons. CNS gene delivery currently relies on invasive intracerebral injection to transit the blood-brain barrier. Non-viral gene delivery via systematic transvascular route is an attractive alternative because it is non-invasive, but a high-yield and targeted gene-expressed method is still lacking. In this study, we propose a novel non-viral gene delivery approach to achieve targeted gene transfection. Cationic microbubbles as gene carriers were developed to allow the stable formation of a bubble-GDNF gene complex, and transcranial focused ultrasound (FUS) exposure concurrently interacting with the bubble-gene complex allowed transient gene permeation and induced local GDNF expression. We demonstrate that the focused ultrasound-triggered GDNFp-loaded cationic microbubbles platform can achieve non-viral targeted gene delivery via a noninvasive administration route, outperform intracerebral injection in terms of targeted GDNF delivery of high-titer GDNF genes, and has a neuroprotection effect in Parkinson's disease (PD) animal models to successfully block PD syndrome progression and to restore behavioral function. This study explores the potential of using FUS and bubble-gene complexes to achieve noninvasive and targeted gene delivery for the treatment of neurodegenerative disease.

SUBMITTER: Fan CH 

PROVIDER: S-EPMC4726227 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Noninvasive, Targeted, and Non-Viral Ultrasound-Mediated GDNF-Plasmid Delivery for Treatment of Parkinson's Disease.

Fan Ching-Hsiang CH   Ting Chien-Yu CY   Lin Chung-Yin CY   Chan Hong-Lin HL   Chang Yuan-Chih YC   Chen You-Yin YY   Liu Hao-Li HL   Yeh Chih-Kuang CK  

Scientific reports 20160120


Glial cell line-derived neurotrophic factor (GDNF) supports the growth and survival of dopaminergic neurons. CNS gene delivery currently relies on invasive intracerebral injection to transit the blood-brain barrier. Non-viral gene delivery via systematic transvascular route is an attractive alternative because it is non-invasive, but a high-yield and targeted gene-expressed method is still lacking. In this study, we propose a novel non-viral gene delivery approach to achieve targeted gene transf  ...[more]

Similar Datasets

| S-EPMC6931095 | biostudies-literature
| S-EPMC3629738 | biostudies-other
| S-EPMC8211807 | biostudies-literature
| S-EPMC5028296 | biostudies-literature
| S-EPMC2927058 | biostudies-literature
| S-EPMC3584045 | biostudies-literature
| S-EPMC3529965 | biostudies-literature
| S-EPMC6414607 | biostudies-literature
| S-EPMC6309225 | biostudies-literature
| S-EPMC10692958 | biostudies-literature